HTT and juvenile Huntington disease: Finally, using a well-established Drosophila melanogaster model for Huntington’s disease (Q128HD-FL), which expresses the mutated form of human huntingtin, the neuronal function improved after MS3 treatment, definitively proving the in vivo efficacy of this aptamer.